Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Assunto principal
País/Região como assunto
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-36901273

RESUMO

Multiple Sclerosis (MS) is characterized by chronic deterioration of the nervous system, mainly the brain and the spinal cord. An individual with MS develops the condition when the immune system begins attacking nerve fibers and the myelin sheathing that covers them, affecting the communication between the brain and the rest of the body and eventually causing permanent damage to the nerve. Patients with MS (pwMS) might experience different symptoms depending on which nerve was damaged and how much damage it has sustained. Currently, there is no cure for MS; however, there are clinical guidelines that help control the disease and its accompanying symptoms. Additionally, no specific laboratory biomarker can precisely identify the presence of MS, leaving specialists with a differential diagnosis that relies on ruling out other possible diseases with similar symptoms. Since the emergence of Machine Learning (ML) in the healthcare industry, it has become an effective tool for uncovering hidden patterns that aid in diagnosing several ailments. Several studies have been conducted to diagnose MS using ML and Deep Learning (DL) models trained using MRI images, achieving promising results. However, complex and expensive diagnostic tools are needed to collect and examine imaging data. Thus, the intention of this study is to implement a cost-effective, clinical data-driven model that is capable of diagnosing pwMS. The dataset was obtained from King Fahad Specialty Hospital (KFSH) in Dammam, Saudi Arabia. Several ML algorithms were compared, namely Support Vector Machine (SVM), Decision Tree (DT), Logistic Regression (LR), Random Forest (RF), Extreme Gradient Boosting (XGBoost), Adaptive Boosting (AdaBoost), and Extra Trees (ET). The results indicated that the ET model outpaced the rest with an accuracy of 94.74%, recall of 97.26%, and precision of 94.67%.


Assuntos
Esclerose Múltipla , Humanos , Estudos Retrospectivos , Arábia Saudita , Encéfalo , Aprendizado de Máquina
2.
Diagnostics (Basel) ; 13(15)2023 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-37568925

RESUMO

Pneumonia, COVID-19, and tuberculosis are some of the most fatal and common lung diseases in the current era. Several approaches have been proposed in the literature for the diagnosis of individual diseases, since each requires a different feature set altogether, but few studies have been proposed for a joint diagnosis. A patient being diagnosed with one disease as negative may be suffering from the other disease, and vice versa. However, since said diseases are related to the lungs, there might be a likelihood of more than one disease being present in the same patient. In this study, a deep learning model that is able to detect the mentioned diseases from the chest X-ray images of patients is proposed. To evaluate the performance of the proposed model, multiple public datasets have been obtained from Kaggle. Consequently, the proposed model achieved 98.72% accuracy for all classes in general and obtained a recall score of 99.66% for Pneumonia, 99.35% for No-findings, 98.10% for Tuberculosis, and 96.27% for COVID-19, respectively. Furthermore, the model was tested using unseen data from the same augmented dataset and was proven to be better than state-of-the-art studies in the literature in terms of accuracy and other metrics.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA